Switzerland's EMS Chemie H1 operating profit rises on price hikes, cost discipline

Ems Chemie Holding AG

10/07/2026 04:48

Overview
Switzerland specialty chemicals maker's provisional H1 net sales declined 0.8% yr/yr, rose in local currencies
Provisional EBIT for H1 increased 4.7% yr/yr, driven by price adjustments and cost discipline
Company says results supported by innovation, price adjustments offsetting higher raw material costs

Outlook
EMS Chemie expects a continuing challenging geopolitical environment in 2026
Company slightly raises 2026 net sales forecast, now expects sales slightly below previous year
Operating income (EBIT) for 2026 expected unchanged, slightly above previous year

Result Drivers
PRICE ADJUSTMENTS - Co said higher raw material costs were offset by sales price increases
COST DISCIPLINE - Co attributed increased profitability to cost discipline and proactive planning
INNOVATION AND NEW BUSINESS - Co said growth was supported by innovative and high-margin new business in all regions

Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
H1 Sales
 
CHF 1.01 bln
 
H1 EBIT
 
CHF 310 mln
 
H1 EBITDA
 
CHF 336 mln
 

Analyst Coverage
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 2 "strong buy" or "buy", 4 "hold" and 2 "sell" or "strong sell"
The average consensus recommendation for the specialty chemicals peer group is "buy."
Wall Street's median 12-month price target for Ems Chemie Holding AG is CHF665.00, about 2.8% below its July 9 closing price of CHF684.50
The stock recently traded at 32 times the next 12-month earnings vs. a P/E of 30 three months ago

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)